Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

A united front in fight against the 'silent pandemic'

Antimicrobial resistance is one of the biggest public health challenges of our time and we’re at a crossroads on how to combat it.

360info

Former Petrobras executive asks Brazil court to block dividend payment

Guilherme Estrella, former director of Brazil's state-controlled oil giant Petrobras, filed a lawsuit in court to block the payment of dividends by the company. In a late Friday filing, Petrobras reported that Estrella, a former director of exploration and production, requested the blocking of 32.1 billion reais ($6.6 billion) in…

Reuters

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Irish pharmacies running low on vital diabetes drug after viral TikTok video reveals weight loss benefits

Hundreds of videos followed with people explaining how the injectables can be used for effective weight loss when prescribed by a GP

Irish Mirror

These companies claim to support abortion rights. They are backing anti-abortion Republicans

An analysis of major companies’ donations, including Meta and Amazon, reveals donations to candidates calling for banning the procedure

The Guardian - US

China posts 6-month high COVID count as it sticks with strategy

China on Sunday reported its highest number of new COVID-19 infections in six months, a day after health officials said they were sticking with strict coronavirus curbs, likely disappointing recent investor hopes for an easing.

Reuters

The COVID drug under a cloud that made billions

'It's a big deal because the Australian government purchased a huge amount of that drug.'

Newcastle Herald

Read news from The Economist, FT, and more,
with one subscription

Regeneron, Bayer offer more promising data for aging eye drug

Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.

Tribune News Service

NHS could pay higher drug prices if Brexit trade deal with India goes ahead

India supplies the NHS with a quarter of its medicines and changes to pharma monopoly rights and patent laws under leaked plans could see costs spiral

Daily Mirror

Public's confidence in vaccines plummets since Covid pandemic

Covid vaccines are estimated to have saved tens of millions of lives during the pandemic

Wales Online

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Speed pill prices plunge to B2 each

Methamphetamine pills, which cost as much as 300 baht apiece in Thailand just a few years ago, can now be had for as little as two baht each, say police who arrested a drug suspect in Lop Buri.

Bangkok Post

Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).

Benzinga

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

High court to hear water dispute between Navajo, government

The Supreme Court will hear a water dispute involving the U.S. government and the Navajo Nation

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Investors Business Daily

This Key Piece Of News Could Spark BioNTech, Moderna — And Stoke Demand For Covid Boosters

Covid vaccine stocks surged Friday after a new study suggested an added benefit of the updated omicron-targeting boosters.

Salon

An epidemic of fentanyl misinformation

More politicians say fentanyl should be deemed a "weapon of mass destruction." Do they even understand what it is?

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Europe OK's 1st one-dose drug to protect babies against RSV

The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year

Investors Business Daily

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth

Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line.

Investors Business Daily

Apellis Pharma Crashes On Unexpected Delay For Eye Drug, Taking A Key Rival With It

Apellis reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric with it.

Evening Standard

‘Vaccine apathy’ slowing down London’s Covid booster rollout

Top health professor warns that over-50s in London must be better protected heading into winter

Insider UK

Healthtech and sustainable start-ups win Scottish innovation awards

Rebecca Goss from the University of St Andrews, who founded X-Genix, takes overall prize

The Independent UK

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

1 … 109 110 111 112

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations